Gene · 445
Papers3,531
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,531
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Controlling nephron precursor differentiation to generate proximal-biased kidney organoids with emerging maturity. | Nat Commun | 2025 | 40885711 | PubTator, text mining | PubMed |
| Coexisting Subdural Hematoma in Cerebral Amyloid Angiopathy: A Case Series. | Neurol Int | 2025 | 40863994 | PubTator, text mining | PubMed |
| Mitochondrial Metabolomics in Cancer: Mass Spectrometry-Based Approaches for Metabolic Rewiring Analysis and Therapeutic Discovery. | Metabolites | 2025 | 40863132 | PubTator, text mining | PubMed |
| Metabolic dysregulation in pulmonary fibrosis: insights into amino acid contributions and therapeutic potential. | Cell Death Discov | 2025 | 40858556 | PubTator, text mining | PubMed |
| Case Report: From coma to genetic insights: identification of a novel pathogenic variant in Chinese neonatal CTLN1. | Front Pediatr | 2025 | 40837674 | PubTator, text mining | PubMed |
| ASS1 inhibits liver cancer by promoting CAD ubiquitination and reversing the urea cycle and pyrimidine synthesis imbalance. | Hepatol Commun | 2025 | 40824254 | PubTator, text mining | PubMed |
| Arginine depletion potentiates standard-of-care chemo-immunotherapy in preclinical models of high-risk neuroblastoma. | J Exp Clin Cancer Res | 2025 | 40813699 | PubTator, text mining | PubMed |
| Long noncoding RNAs regulating enzymatic reactions in cancer. | Exp Mol Med | 2025 | 40804479 | PubTator, text mining | PubMed |
| Clinical characteristics and long-term outcomes of 101 patients with urea cycle disorders in China. | Orphanet J Rare Dis | 2025 | 40804416 | PubTator, text mining | PubMed |
| An ancient enhancer rapidly evolving in the human lineage promotes neural development and cognitive flexibility. | Sci Adv | 2025 | 40802760 | PubTator, text mining | PubMed |
| m6A-Modified circRAPGEF1 Interaction with IGF2BP3 Promotes Hepatocellular Carcinoma Progression via Reprogramming Aspartate Metabolism. | Adv Sci (Weinh) | 2025 | 40801445 | PubTator, text mining | PubMed |
| Integrated multiple machine learning and Mendelian randomization reveal LTF gene as a prognostic biomarker for nonspecific orbital inflammation. | BMC Pharmacol Toxicol | 2025 | 40760708 | PubTator, text mining | PubMed |
| PPARγ-induced upregulation of fatty acid metabolism confers resistance to venetoclax and decitabine therapy in AML. | Blood Neoplasia | 2025 | 40757392 | PubTator, text mining | PubMed |
| Metabolomics and proteomics reveal blocking argininosuccinate synthetase 1 alleviates colitis in mice. | Nat Commun | 2025 | 40739098 | PubTator, text mining | PubMed |
| Beyond the Limit: MYC Mediates Tumor Immune Escape. | Pharmaceuticals (Basel) | 2025 | 40732268 | PubTator, text mining | PubMed |
| Exogenous arginine differentially regulates inflammatory cytokine and inducible nitric oxide synthase expression in macrophages. | Immunohorizons | 2025 | 40694828 | PubTator, text mining | PubMed |
| Invasive lobular carcinoma: integrated multi-omics analysis reveals silencing of Argininosuccinate synthase and upregulation of nucleotide biosynthesis in tamoxifen resistance. | Cell Death Dis | 2025 | 40645971 | PubTator, text mining | PubMed |
| [Morphomolecular subtyping of hepatocellular adenoma]. | Pathologie (Heidelb) | 2025 | 40471284 | PubTator, text mining | PubMed |
| Arginine promotes the activation of human lung fibroblasts independent of its metabolism. | Biochem J | 2025 | 40454944 | PubTator, text mining | PubMed |
| Lacticaseibacillus rhamnosus GG-driven remodeling of arginine metabolism mitigates gut barrier dysfunction. | Am J Physiol Gastrointest Liver Physiol | 2025 | 40418622 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/445/papers?page=6